Lipocine Operating Inc is a clinical-stage biopharmaceutical company based in Salt Lake City, UT, specializing in innovative solutions for metabolic and endocrine disorders. Their proprietary drug delivery technologies focus on improving compliance and absorption for better patient outcomes.
With a progressive pipeline of oral therapies like TLANDO and LPCN 1154, Lipocine is dedicated to developing treatments for conditions such as postpartum depression, NASH, and recurrent pre-term birth. Their pioneering Lip'RAL technology enables efficient absorption of water-insoluble drugs, aiming to revolutionize the face of oral absorption drugs.
Generated from the website